Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016 Jan 13; 8(321):321ra5.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Behavior
Cognition
Demography
DNA Methylation
Double-Blind Method
Female
Fragile X Syndrome
Humans
Indoles
Least-Squares Analysis
Male
Placebos
Treatment Outcome
authors with profiles
Elizabeth Berry-Kravis